Dual-action hope: DeepSeek responses to Tirzepatide’s role in metabolic health

Abstract

DeepSeek is an artificial intelligence (AI) platform introduced on January 2025. It is built on deep learning and natural language processing (NLP) technologies. Its core products include the DeepSeek-R1 and DeepSeek-V3 models.¹ A prominent feature of DeepSeek's framework is its support for offline deployment. This capability may enable healthcare institutions to adapt a local LLM (large language model) and operate the model without an internet connection, thereby enhancing data privacy and security.² DeepSeek has set tremendous path by lower computational costs compared to other proprietary LLMs, making AI more accessible to everyone. In medical education, educators can create case simulations for tutoring students. The model's ability to process and generate human-like text enables the development of realistic patient interactions, enhancing the training of future healthcare professionals.³ Having large updated database, doctors and patients can now use this as new tool to update themselves in new innovations in field of medicine